X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (211) 211
life sciences & biomedicine (201) 201
humans (195) 195
gastroenterology & hepatology (123) 123
male (116) 116
female (114) 114
adult (100) 100
gastroenterology and hepatology (77) 77
inflammatory bowel disease (74) 74
middle aged (74) 74
ulcerative colitis (72) 72
crohn's disease (61) 61
crohn disease - genetics (53) 53
aged (50) 50
adolescent (44) 44
genetic predisposition to disease (42) 42
colitis, ulcerative - genetics (38) 38
polymorphism, single nucleotide (36) 36
risk factors (35) 35
genetic aspects (33) 33
case-control studies (32) 32
genotype (32) 32
young adult (32) 32
abridged index medicus (29) 29
genetics & heredity (28) 28
treatment outcome (27) 27
genetics (26) 26
inflammatory bowel diseases (26) 26
inflammatory bowel diseases - genetics (26) 26
genome-wide association study (25) 25
medical research (25) 25
child (24) 24
research (22) 22
analysis (21) 21
italy (21) 21
aged, 80 and over (19) 19
colitis, ulcerative - drug therapy (19) 19
crohn’s disease (19) 19
digestive system diseases (19) 19
follow-up studies (19) 19
care and treatment (18) 18
gastroenterology (18) 18
genes (17) 17
alleles (16) 16
phenotype (16) 16
cohort studies (15) 15
crohn disease - drug therapy (15) 15
gene expression (15) 15
genetic variation (15) 15
genomics (15) 15
medicine, experimental (15) 15
severity of illness index (15) 15
studies (15) 15
gene frequency (14) 14
infliximab (14) 14
medicin och hälsovetenskap (14) 14
polymorphism, single nucleotide - genetics (14) 14
animals (13) 13
child, preschool (13) 13
medical and health sciences (13) 13
achalasia (12) 12
genomes (12) 12
inflammatory bowel diseases - drug therapy (12) 12
intestine (12) 12
nod2 signaling adaptor protein - genetics (12) 12
oncology (12) 12
pharmacology & pharmacy (12) 12
time factors (12) 12
crohn disease (11) 11
haplotypes (11) 11
medicine (11) 11
prospective studies (11) 11
risk (11) 11
colitis, ulcerative - pathology (10) 10
crohn disease - pathology (10) 10
immunology (10) 10
inflammatory-bowel-disease (10) 10
multidisciplinary sciences (10) 10
remission induction (10) 10
science & technology - other topics (10) 10
surgery (10) 10
age of onset (9) 9
antibodies, monoclonal - therapeutic use (9) 9
autoimmune diseases (9) 9
clinical medicine (9) 9
genetic predisposition to disease - genetics (9) 9
genetic research (9) 9
health aspects (9) 9
inflammatory bowel diseases - immunology (9) 9
klinisk medicin (9) 9
meta-analysis (9) 9
quantitative trait loci (9) 9
retrospective studies (9) 9
single nucleotide polymorphisms (9) 9
usage (9) 9
biochemistry & molecular biology (8) 8
colitis, ulcerative - immunology (8) 8
colonoscopy (8) 8
crohn disease - immunology (8) 8
crohn disease - metabolism (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 01/2016, Volume 387, Issue 10014, pp. 156 - 167
Journal Article
Journal Article
Pharmacological research, ISSN 1043-6618, 09/2020, Volume 159, pp. 104892 - 104892
[Display omitted] Inflammatory bowel diseases (IBD) are chronic intermittent inflammatory disorders of the gastrointestinal tract of unknown etiology but a... 
Genetic | Genome-wide association study (GWAS) | Crohn's disease (CD) | Epigenetic | Inflammatory bowel disease (IBD) | Ulcerative colitis (UC) | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Index Medicus
Journal Article
Digestive diseases and sciences, ISSN 0163-2116, 2019, Volume 64, Issue 6, pp. 1399 - 1400
... Breeds Contented Patients Vito Annese1 Published online: 6 February 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 The introduction... 
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Crohn Disease | Antibodies, Monoclonal | Infliximab | Biosimilar Pharmaceuticals | Humans | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Inflammatory bowel diseases, ISSN 1078-0998, 01/2020, Volume 26, Issue 2, pp. 271 - 272
Therapeutic drug monitoring (TDM) for anti-TNFα agents hass gained an increased momentum; although it is surely recommended in case of loss of response, its... 
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Infliximab | Drug Monitoring | Inflammatory Bowel Diseases | Tumor Necrosis Factor-alpha | Humans | Gastrointestinal Agents | Index Medicus
Journal Article
by Anderson, Carl A and Boucher, Gabrielle and Lees, Charlie W and Franke, Andre and D'Amato, Mauro and Taylor, Kent D and Lee, James C and Goyette, Philippe and Imielinski, Marcin and Latiano, Anna and Lagacé, Caroline and Scott, Regan and Amininejad, Leila and Bumpstead, Suzannah and Baidoo, Leonard and Baldassano, Robert N and Barclay, Murray and Bayless, Theodore M and Brand, Stephan and Büning, Carsten and Colombel, Jean-Frédéric and Denson, Lee A and De Vos, Martine and Dubinsky, Marla and Edwards, Cathryn and Ellinghaus, David and Fehrmann, Rudolf S N and Floyd, James A B and Florin, Timothy and Franchimont, Denis and Franke, Lude and Georges, Michel and Glas, Jürgen and Glazer, Nicole L and Guthery, Stephen L and Haritunians, Talin and Hayward, Nicholas K and Hugot, Jean-Pierre and Jobin, Gilles and Laukens, Debby and Lawrance, Ian and Lémann, Marc and Levine, Arie and Libioulle, Cecile and Louis, Edouard and McGovern, Dermot P and Milla, Monica and Montgomery, Grant W and Morley, Katherine I and Mowat, Craig and Ng, Aylwin and Newman, William and Ophoff, Roel A and Papi, Laura and Palmieri, Orazio and Peyrin-Biroulet, Laurent and Panés, Julián and Phillips, Anne and Prescott, Natalie J and Proctor, Deborah D and Roberts, Rebecca and Russell, Richard and Rutgeerts, Paul and Sanderson, Jeremy and Sans, Miquel and Schumm, Philip and Seibold, Frank and Sharma, Yashoda and Simms, Lisa A and Seielstad, Mark and Steinhart, A Hillary and Targan, Stephan R and van den Berg, Leonard H and Vatn, Morten and Verspaget, Hein and Walters, Thomas and Wijmenga, Cisca and Wilson, David C and Westra, Harm-Jan and Xavier, Ramnik J and Zhao, Zhen Z and Ponsioen, Cyriel Y and Andersen, Vibeke and Torkvist, Leif and Gazouli, Maria and Anagnou, Nicholas P and Karlsen, Tom H and Kupcinskas, Limas and Sventoraityte, Jurgita and Mansfield, John C and Kugathasan, Subra and Silverberg, Mark S and Halfvarson, Jonas and Rotter, Jerome I and Mathew, Christopher G and Griffiths, Anne M and Gearry, Richard and Ahmad, Tariq and Brant, Steven R and Chamaillard, Mathias and ...
Nature genetics, ISSN 1546-1718, 02/2011, Volume 43, Issue 3, pp. 246 - 252
Genome-wide association studies and candidate gene studies in ulcerative colitis have identified 18 susceptibility loci. We conducted a meta-analysis of six... 
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Crohn Disease - genetics | Risk | Genome-Wide Association Study | Humans | Colitis, Ulcerative - genetics | Genetic aspects | Disease susceptibility | Research | Risk factors | Ulcerative colitis | Meta-analysis | Studies | Inflammatory bowel disease | Celiac disease | Genetics | Genomics | Genes | Index Medicus
Journal Article
Journal Article
Drug design, development and therapy, ISSN 1177-8881, 06/2017, Volume 11, pp. 1653 - 1661
The introduction of biological agents has revolutionized the management of many life-threatening and debilitating immune-mediated diseases. Because of the high... 
Infliximab | CT-P13 | Biosimilar | Biologic therapy | Crohn’s disease | Ulcerative colitis | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Humans | Inflammatory Bowel Diseases - immunology | Antibodies, Monoclonal - adverse effects | Inflammatory Bowel Diseases - diagnosis | Antibodies, Monoclonal - therapeutic use | Infliximab - therapeutic use | Colitis, Ulcerative - immunology | Infliximab - pharmacokinetics | Joint Diseases - diagnosis | Spondylitis, Ankylosing - immunology | Infliximab - adverse effects | Joint Diseases - drug therapy | Anti-Inflammatory Agents - adverse effects | Arthritis, Rheumatoid - drug therapy | Drug Design | Anti-Inflammatory Agents - therapeutic use | Antirheumatic Agents - adverse effects | Biosimilar Pharmaceuticals - pharmacokinetics | Product Surveillance, Postmarketing | Anti-Inflammatory Agents - pharmacokinetics | Colitis, Ulcerative - drug therapy | Antirheumatic Agents - therapeutic use | Joint Diseases - immunology | Inflammatory Bowel Diseases - drug therapy | Biosimilar Pharmaceuticals - therapeutic use | Spondylitis, Ankylosing - drug therapy | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Crohn Disease - immunology | Biosimilar Pharmaceuticals - adverse effects | Animals | Crohn Disease - drug therapy | Antirheumatic Agents - pharmacokinetics | Arthritis, Rheumatoid - immunology | Drug Substitution | Pharmaceutical research | Biosimilar pharmaceuticals | Forecasts and trends | Drug discovery | Innovations | Health care | Drugs | Inflammatory bowel diseases | Clinical trials | Arthritis | Regulatory approval | Immunosuppressive agents | Anticancer properties | Intestine | Gastroenterology | Colon | Pharmaceutical industry | Product safety | Ankylosing spondylitis | Public health | Medical research | Biological products | Pharmacology | FDA approval | Tumor necrosis factor-α | Gene expression | Disease control | Patients | Cost control | Quality of life | Inflammatory bowel disease | Studies | Spondylitis | Immunogenicity | Rheumatoid arthritis | Monoclonal antibodies | Index Medicus | Crohn disease | biologic therapy | Ulcerative Colitis | biosimilar
Journal Article
Journal Article